Cholesterol microcrystals and cochleate cylinders: Attachment of pyolysin oligomers and domain 4

Journal of Structural Biology

Volumn 173, Issue 1, 2011, Pages 38-45

  Harris, J Robin ^a,b   Lewis, Richard J ^a   Baik, Clara ^c   Pokrajac, Lisa ^c   Billington, Stephen J ^d   Palmer, Michael ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF WATERLOO   (Canada)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cholesterol; Cochleate cylinder; Domain 4; Microcrystal; Negative staining; Pyolysin

Indexed keywords

CARBON; CHOLESTEROL; MEMBRANE PROTEIN; OLIGOMER; PYOLYSIN; STREPTOLYSIN O; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL; ELECTRON; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CHOLESTEROL; DNA PRIMERS; HEMOLYSIN PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR CONFORMATION; POLYMERIZATION; STAINING AND LABELING; TEMPERATURE;

EID: 78649908803     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2010.07.010     Document Type: Article

References (61)

1. Abdel-Ghani E.M., Weis S., Walev I., Kehoe M., Bhakdi S., Palmer M. Streptolysin O: inhibition of the conformational change during membrane binding of the monomer prevents oligomerization and pore formation. Biochemistry 1999, 38:15204-15211.
2. Alouf J.E. Cholesterol-binding cytolytic protein toxins. Int. J. Med. Microbiol. 2000, 290:351-356.
3. Alouf J.E., Geoffroy C. The family of the antigenically related, cholesterol-binding (" sulphydryl-activated" ) cytolytic toxins. Sourcebook of Bacterial Toxins 1991, 147-186. Academic Press, Berlin. J.J. Freer, J.E. Alouf (Eds.).
4. Archibald D.D., Mann S. Structural studies of lipid fibers formed by sphingosine. Biochim. Biophys. Acta 1993, 1166:154-162.
5. Baba H., Kaweamura I., Kohda C., Nomura T., Ito Y., Kimoto T., Watanabe I., Ichiyama S., Mitsuyama M. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Biochim. Biophys. Res. Commun. 2001, 281:37-44.
6. Billington S.J., Jost B.H., Cuevas W.A., Bright K.R., Songer J.G. The Arcanobacteirum (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J. Bacteriol. 1997, 179:6100-6106.
7. Billington S.J., Songer J.G., Jost B.H. Molecular characterization of the pore-forming toixn, pyolysin, a major virulence determinant of Arcanobacteium pyogenes. Vet. Microbiol. 2001, 82:261-274.
8. Billington S.J., Songer J.G., Jost B.H. The variant undecapeptide sequence of the Arcanobacterium pyogenes hemolysin, pyolysin, is required for full cytolytic activity. Microbiology 2002, 148:3947-3954.
9. Chung D.S., Benedek G.B., Konikoff F.M., Donovan J.M. Elastic free energy of anisotropic helical ribbons as a metastable intermediates in the crystallization of cholesterol. Proc. Natl. Acad. Sci. USA 1993, 90:11341-11345.
10. Craven B.M. Crystal structure of cholesterol monohydrate. Nature 1976, 260:727-729.
11. Czajkowsky D.M., Hotze E.M., Shao Z., Tweten R.K. Vertical collapse of a cytolysin prepore moves its transmembrane β-hairpins to the membrane. EMBO J. 2004, 23:3206-3215.
12. Dang T.X., Hotze E.M., Rouiller I., Tweten R.K., Wilson-Kubalek E.M. Prepore to pore transition of a cholesterol-dependent cytolysin visualized by electron microscopy. J. Struct. Biol. 2005, 150:100-108.
13. Deamer D.W. Preparation and properties of ether-injection liposomes. Ann. N.Y. Acad. Sci. 1978, 308:250-258.
14. Evans C.C., Zasadzinski J. Encapsulating vesicles and colloids from cochleate cylinders. Langmuir 2003, 19:3109-3113.
15. Farrand A.J., LaChapelle S., Hotze E.M., Johnson A.E., Tweten R.K. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. USA 2010, 107:4341-4346.
16. Gilbert R.J.C., Jiménez J.L., Chen S., Tickle I.J., Rossjohn J., Parker M., Andrew P.W., Saibil H.R. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 1999, 97:647-655.
17. Goldstein A.S., Lukyanov A.N., Carlson P.A., Yager P., Gelb M.H. Formation of high-axial-ratio-microstructures from natural and synthetic sphingolipids. Chem. Phys. Lipids 1997, 88:21-36.
18. Haberland M.E., Reynolds J.A. Self-association of cholesterol in aqueous solution. Proc. Natl. Acad. Sci. USA 1973, 70:2313-2316.
19. Harris J.R. Electron microscopy of cholesterol. Micron 1988, 19:19-32.
20. Harris J.R. Negative Staining and Cryoelectron Microscopy. RMS Microscopy Handbook No. 35 1997, BIOS Scientific Publishers Ltd., Oxford.
21. Harris J.R., Adrian M., Bhakdi S., Palmer M. Cholesterol-streptolysin O interaction: an EM study of Wild-type and mutant streptolysin O. J. Struct. Biol. 1998, 121:343-355.
22. Harris J.R., Bhakdi S., Meissner U., Scheffler D., Bittman R., Li G., Zitzer A., Palmer M. Interaction of the Vibrio cholerae cytolysin (VCC) with cholesterol, some cholesterol esters, and cholesterol derivatives: a TEM study. J. Struct. Biol. 2002, 139:122-135.
23. Heuck A.P., Hotze E.M., Tweten R.K., Johnson A.E. Mechanism of membrane insertion of a multimeric β-barrel protein: Perfingolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell 2000, 6:1233-1242.
24. Heuck A.P., Moe P.C., Johnson B.B. The cholesterol-dependent cytolysins family of gram-positive toxins. Subcellular Biochemistry 2010, vol. 51. Springer. J.R. Harris (Ed.).
25. Heuck A.P., Saavva C.G., Holzenburg A., Johnson A.E. Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin upon binding to cholesterol. J. Biol. Chem. 2007, 282:22629-22637.
26. Heuck A.P., Tweten R.K., Johnson A.E. Assembly and topography of the prepore complex in cholesterol-dependent cytolysins. J. Biol. Chem. 2003, 278:31218-31225.
27. Hsu L.-Y., Nordman C.E. Phase transition and crystal structure of the 37C form of cholesterol. Science 1983, 220:604-606.
28. Kellner-Weibel G., Yancey P.G., Jerome W.G., Walser T., Mason R.P., Phillips M.C., Rothblat G.H. Crystallization of free cholesterol in model macrophage foam cells. Atheroscler. Thromb. Vasc. Biol. 1999, 19:1891-1898.
29. Khaykovich B., Hossain C., McManus J.J., Lomakin A., Moncton D.E. Structure of cholesterol helical ribbons and self-assembling springs. Proc. Natl. Acad. Sci. USA 2007, 104:9656-9660.
30. Klinkner A.M., Waites C.R., Kerns W.D., Bugelski P.J. Evidence of foam cell and cholesterol crystal formation in macrophages incubated with oxidized LDL by fluorescence and electron microscopy. J. Histochem. Cytochem. 1995, 43:1071-1078.
31. Komura S., Zhong-can O.-Y. low-pitch helical structure of tolted chiral lipid bilayers. Phys. Rev. Lett. 1998, 81:473-476.
32. Konikoff F.M., Chung D.S., Donovan J.M., Small D.M., Carey M.C. Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates. J. Clin. Invest. 1992, 90:1155-1160.
33. Loomis C.R., Shipley G.G., Small D.M. The phase behaviour of hydrated cholesterol. J. Lipid Res. 1979, 20:525-535.
34. Miclea R.D., Varma P.R., Peng A., Balu-Iyer S.V. Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochim. Biophys. Acta 2007, 1768:2890-2898.
35. Mitsui K., Sekiya T., Okamura S., Yoshinori N., Hase J. Biochim. Biophys. Acta 1979, 558:307-313.
36. Nagamune H., Ohkura K., Sukeno A., Cowan G., Mitchell T.J., Ito W., Ohnishi O., Kanako H., Yamato M., Hiroto K., Miyake Y., Maeda T., Kourai H. The human-specific action of intermedilysin, a homologue of streptolysin O, is dictated by domain 4 of the protein. Microbiol. Immunol. 2004, 48:677-692.
37. Nelson L.D., Johnson A.E., London E. How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological pH. J. Biol. Chem. 2008, 263:4632-4642.
38. Ohno-Iwashita Y., Shimada Y., Waheed A.A., Hayashi M., Inomata M., Nakamura M., Maruya M., Iwashita S. Perfringolysin O, a cholesterol-binding cytolysin, as aprobe for lipid rafts. Anaerobe 2004, 10:125-134.
39. Ohno-Iwashita Y., Shimada Y., Hayashi M., Iwamoto M., Iwashita S., Imnomata M. Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization. Subcellular Biochemistry 2010, vol. 51. Springer. J.R. Harris (Ed.).
40. Palmer M., Harris J.R., Freytag C., Kehoe M., Tranum-Jensen J., Bhakdi S. Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization. EMBO J. 1998, 17:1598-1605.
41. Papahadjopoulos D., Vail W.J., Jacobson K., Poste E. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta 1975, 394:483-491.
42. Perl-Treves D., Kessler N., Izhaky D., Addadi L. Monoclonal antibody recognition of cholesterol monohydrate crystal faces. Chem. Biol. 1996, 3:567-577.
43. Pham H.L., Shaw P.N., Davies N.M. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection. Int. J. Pharmaceut. 2006, 310:196-202.
44. Piccoli G.B., Fenoglio R., Colla L., Bilucaglia D., Messa E., Burdese M., Bermond F., Segoloni G.P. Cholesterol crystal embolism syndrome in dialysis patients: an emerging clinical diagnosis. Blood Purif. 2006, 24:433-438.
45. Polekhina G., Giddings K.S., Tweten R.K., Parker M.W. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc. Natl. Acad. Sci. USA 2005, 102:600-605.
46. Ramachandran R., Heuck A.P., Tweten R.K., Johnson A.E. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nature Struct. Biol. 2002, 9:823-827.
47. Ravoo B.J., Stuart M.C.A., Brisson A.D.R., Weringa W.D., Engberts J.B.F.N. Electron microscopic investigations of the morphology and calcium-induced fusion of lipid vesicles with an oligomerised inner leaflet. Chem. Phys. Lipids 2001, 109:63-74.
48. Rossjohn J., Polekhina G., Feil S.C., Morton C.J., Tweten R.K., Parker M.W. Structure of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J. Mol. Biol. 2007, 367:1227-1236.
49. Schubert M.A., Müller-Goymann C.C. Solvent injection as a new approach for manufacturing lipid nanoparticles - evaluation of the method and process parameters. Eur. J. Pharmaceut. Biopharmaceut. 2003, 55:125-131.
50. Sekiya K., Akagi T., Tatsuta K., Sakakura E., Hashikawa T., Abe A., Nagamune H. Ultrastructural analysis of the membrane insertion of domain 3 of streptolysin O. Microbes Infect. 2007, 9:1341-1350.
51. Shumada Y., Maruya M., Iashita S., Ohno-Iwashita Y. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur. J. Biochem. 2002, 269:6195-6203.
52. Solomonov I., Weygand M.J., Kjaer K., Rapaport H., Leiserowitz L. Trapping crystal nucleation of cholesterol monohydrate: relevance to pathological crystallization. Biophys. J. 2005, 88:1809-1817.
53. Soltani C.E., Hotze E.M., Johnso A.E., Tweten R.K. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J. Biol. Chem. 2007, 282:15709-15716.
54. Sonnen A.F.-P., Rowe A.J., Andrew P.W., Gilbert R.J.C. Oligomerization of pneumolysin on cholesterol crystals: similarities to the behaviour of polyene antibiotics. Toxicon 2008, 51:1554-1559.
55. Syed U.M., Woo A.F., Plakogiannis F., Jin T., Zhu H. Cochleates bridged by drug molecules. Int. J. Pharmaceut. 2008, 363:118-125.
56. Tilley S.J., Orlova E.V., Gilbert R.J.C., Andrew P.W., Saibil H.R. Structural basis of pore promation by the bacterial toxin pneumolysin. Cell 2005, 121:247-256.
57. Weis S., Palmer M. Streptolysin O: the C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization. Biochem. Biophys. Acta 2001, 1510:292-299.
58. Weller U., M.Müller L., Meissner M., Palmer M., Valeva A., Tranum-Jensen J., Agrawal p., Biermann C., Döbereiner A., Kehoe M., Bhakdi S. Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein-streptolysin-O fusion protein. Eur. J. Biochem. 1996, 236:34-39.
59. Wells B., Horne R.W. The ultrastructure of Pseudomonas avenae II. Intracellular refractile (R-body) structure. Micron Microsc. Acta 1983, 14:329-344.
60. Zarif L. Elongated supramolecular assemblies in drug delivery. J. Cont. Release 2002, 81:7-23.
61. Zarif, L., Perlin, D.S., 2002. Amphotericin B nanochochleates; from formulation to cochleate technology. Drug Deliv.Technol. 2 June: posted on-line 3/28/2008.